MH

Merajul Hassan

Active Director Designated Partner DIN 08876153
DIN 08876153 First appointment Sep 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Merajul Hassan

Data last updated:

Merajul Hassan is a Designated Partner at Genykep India Pharmaceutical Llp (since 2020). The company operates in Pharma.

DIN 08876153
Primary Designation Designated Partner
Industry Pharma
First Appointment 17 Sep 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner17 Sep 20202020Active

Board colleagues of Merajul Hassan

NameDINCompanyDesignation
Mohammad Parvez08581255Genykep India Pharmaceutical LlpDesignated Partner
Mohd Khalidur Rahman08876044Genykep India Pharmaceutical LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Genykep India Pharmaceutical Llp
Premium access

Shareholding and investment profile for Merajul Hassan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Merajul Hassan

Merajul Hassan currently holds 1 directorship: Genykep India Pharmaceutical Llp (Designated Partner, since 17 Sep 2020).

Merajul Hassan was first appointed on 17 Sep 2020 as Designated Partner at Genykep India Pharmaceutical Llp.

The current boards of Merajul Hassan's companies include Mohammad Parvez (Genykep India Pharmaceutical Llp), Mohd Khalidur Rahman (Genykep India Pharmaceutical Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available